Page last updated: 2024-10-30

metformin and Adenocarcinoma, Papillary

metformin has been researched along with Adenocarcinoma, Papillary in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"This association is less clear in epithelial ovarian cancer (EOC)."1.40Diabetes mellitus and ovarian cancer: more complex than just increasing risk. ( Daily, LB; Erickson, BK; Fauci, JM; Haygood, CW; Leath, CA; Martin, JY; Matin, T; McGwin, G; Pasko, D; Shah, MM, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shah, MM1
Erickson, BK1
Matin, T1
McGwin, G1
Martin, JY1
Daily, LB1
Pasko, D1
Haygood, CW1
Fauci, JM1
Leath, CA1

Other Studies

1 other study available for metformin and Adenocarcinoma, Papillary

ArticleYear
Diabetes mellitus and ovarian cancer: more complex than just increasing risk.
    Gynecologic oncology, 2014, Volume: 135, Issue:2

    Topics: Adenocarcinoma, Papillary; Aged; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Comorbidity

2014